,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,,,,,,,,,,,s,"N-degron, 1-4, ELM",,,,,,,,,,,
1,2,K,,,,,,,,,,,s,"N-degron, 1-4, ELM",,,,,,,,,,,
2,3,L,,,,,,,,,,,s,"N-degron, 1-4, ELM|PP2A holoenzyme B56-docking site, 3-9, ELM",,,,,,,,,,,
3,4,Q,,,,,,,,,,,s,"N-degron, 1-4, ELM|PP2A holoenzyme B56-docking site, 3-9, ELM",,,,,,,,,,,
4,5,A,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 3-9, ELM",,,,,,,,,,,
5,6,V,M,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 3-9, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929544-929544","hg19,19:g.929544G>A",0.136,,,,
6,7,M,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 3-9, ELM",,,,,,,,,,,
7,8,E,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 3-9, ELM",,,,,,,,,,,
8,9,T,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 3-9, ELM",,,,,,,,,,,
9,10,L,,,,,,,,,,,s,,,,,,,,,,,,
10,11,L,,,,,,,,,,,s,,,,,,,,,,,,
11,12,Q,,,,,,,,,,,s,,,,,,,,,,,,
12,13,R,,,,,,,,,,,s,,,,,,,,,,,,
13,14,Q,,,,,,,,,,,d,,,,,,,,,,,,
14,15,Q,,,,,,,,,,,d,,,,,,,,,,,,
15,16,R,,,,,,,,,,,d,,,,,,,,,,,,
16,17,A,,,,,,,,,,,d,"TRAF2 binding site, 17-20, ELM",,,,,,,,,,,
17,18,R,C,,,,,,,,,,d,"TRAF2 binding site, 17-20, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929580-929580","hg19,19:g.929580C>T",0.074,,,,
18,19,Q,,,,,,,,,,,d,"TRAF2 binding site, 17-20, ELM",,,,,,,,,,,
19,20,E,,,,,,,,,,,d,"TRAF2 binding site, 17-20, ELM",,,,,,,,,,,
20,21,L,,,,,,,,,,,d,,,,,,,,,,,,
21,22,E,D,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929594-929594","hg38,19:g.929594G>T",0.140,breast,"carcinoma, ductal_carcinoma",,
22,23,A,,,,,,,,,,,d,,,,,,,,,,,,
23,24,R,Q,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929599-929599","hg19,19:g.929599G>A",0.071,,,,
24,24,R,W,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929598-929598","hg19,19:g.929598C>T",0.086,,,,
25,25,Q,,,,,,,,,,,d,"SH3 ligand, 25-31, ELM",,,,,,,,,,,
26,26,Q,,,,,,,,,,,d,"SH3 ligand, 25-31, ELM|SH3 ligand, 26-32, ELM",,,,,,,,,,,
27,27,L,,,,,,,,,,,d,"SH3 ligand, 25-31, ELM|SH3 ligand, 26-32, ELM",,,,,,,,,,,
28,28,P,,,,,,,,,,,d,"SH3 ligand, 25-31, ELM|SH3 ligand, 26-32, ELM",,,,,,,,,,,
29,29,P,,,,,,,,,,,d,"SH3 ligand, 25-31, ELM|SH3 ligand, 26-32, ELM|SH3 ligand, 29-35, ELM",,,,,,,,,,,
30,30,D,N,,,,,,,,,,d,"SH3 ligand, 25-31, ELM|SH3 ligand, 26-32, ELM|SH3 ligand, 29-35, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929616-929616","hg19,19:g.929616G>A",0.040,,,,
31,31,P,,,,,,,,,,,d,"SH3 ligand, 25-31, ELM|SH3 ligand, 26-32, ELM|SH3 ligand, 29-35, ELM",,,,,,,,,,,
32,32,P,,,,,,,,,,,d,"SH3 ligand, 26-32, ELM|SH3 ligand, 29-35, ELM",,,,,,,,,,,
33,33,A,,,,,,,,,,,d,"SH3 ligand, 29-35, ELM",,,,,,,,,,,
34,34,A,,,,,,,,,,,d,"SH3 ligand, 29-35, ELM",,,,,,,,,,,
35,35,P,R,,,,,,,,,,d,"SH3 ligand, 29-35, ELM",,COSMIC,,,"hg38,19:929632-929632","hg38,19:g.929632C>G",0.015,liver,"other, neoplasm",,
36,36,P,,,,,,,,,,,d,,,,,,,,,,,,
37,37,G,,,,,,,,,,,d,,,,,,,,,,,,
38,38,R,W,,,,,,,,,,d,,,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,19:929640-929640","hg19,19:g.929640C>T",0.067,,,,
39,39,A,,,,,,,,,,,d,,,,,,,,,,,,
40,40,R,,,,,,,,,,,d,,,,,,,,,,,,
41,41,A,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
42,42,A,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
43,43,P,S,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,cBioPortal,pptc_2019,Mixed Cancer Types,"hg19,19:929655-929655","hg19,19:g.929655C>T",0.029,,,,
44,43,P,T,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929655-929655","hg19,19:g.929655C>A",0.032,,,,
45,44,D,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
46,45,E,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
47,46,D,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
48,47,R,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
49,48,E,,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,,,,,,,,,,
50,49,P,S,,,,,,,,,,d,"TRAF6 binding site, 41-49, ELM",,COSMIC,,,"hg38,19:929673-929673","hg38,19:g.929673C>T",0.063,"skin, upper_arm",malignant_melanoma,,
51,50,E,,,,,,,,,,,d,,,,,,,,,,,,
52,51,S,,,,,,,,,,,d,,,,,,,,,,,,
53,52,A,V,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929683-929683","hg38,19:g.929683C>T",0.039,stomach,carcinoma,,
54,53,R,Q,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929686-929686","hg38,19:g.929686G>A",0.031,stomach,"carcinoma, signet_ring_adenocarcinoma",0.0000963251938545,0.0001279099513942
55,54,M,,,,,,,,,,,d,,,,,,,,,,,,
56,55,Q,,,,,,,,,,,d,,,,,,,,,,,,
57,56,R,W,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929694-929694","hg38,19:g.929694C>T",0.117,thyroid,carcinoma,0.0000293689206334,
58,57,A,,,,,,,,,,,d,,,,,,,,,,,,
59,58,Q,,,,,,,,,,,d,,,,,,,,,,,,
60,59,M,,,,,,,,,,,d,,,,,,,,,,,,
61,60,A,V,,,,,,,,,,d,,,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:929707-929707","hg19,19:g.929707C>T",0.239,,,,
62,61,A,T,,,,,,,,,,d,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,19:929709-929709, hg38,19:929709-929709","hg19,19:g.929709G>A, hg38,19:g.929709G>A",0.143,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000176010889207,
63,61,A,V,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929710-929710","hg38,19:g.929710C>T",0.182,large_intestine,"carcinoma, adenocarcinoma",,
64,62,L,,,,,,,,,,,d,,,,,,,,,,,,
65,63,A,,,,,,,,,,,d,,,,,,,,,,,,
66,64,A,,,,,,,,,,,d,,,,,,,,,,,,
67,65,M,,,,,,,,,,,d,,,,,,,,,,,,
68,66,R,Q,,,,,,,,,,d,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,19:929725-929726, hg38,19:929725-929726","hg19,19:g.929725_929726delinsAA, hg38,19:g.929725_929726delinsAA",,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
69,67,A,G,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929728-929728","hg19,19:g.929728C>G",0.151,,,,
70,67,A,V,,,,,,,,,,d,,,cBioPortal,angs_painter_2020,Angiosarcoma,"hg19,19:929728-929728","hg19,19:g.929728C>T",0.131,,,0.0000000000000000,
71,68,A,,,,,,,,,,,d,,,,,,,,,,,,
72,69,A,V,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929734-929734","hg19,19:g.929734C>T",0.119,,,,
73,70,A,T,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929736-929736","hg19,19:g.929736G>A",0.177,,,,
74,70,A,V,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929737-929737","hg38,19:g.929737C>T",0.216,"large_intestine, colon, descending","carcinoma, adenocarcinoma",0.0000501366222958,
75,71,G,,,,,,,,,,,d,,,,,,,,,,,,
76,72,L,,,,,,,,,,,d,"SH3 ligand, 72-78, ELM",,,,,,,,,,,
77,73,G,,,,,,,,,,,d,"SH3 ligand, 72-78, ELM",,,,,,,,,,,
78,74,H,,,,,,,,,,,d,"WW domain ligands, 74-79, ELM|SH3 ligand, 72-78, ELM",,,,,,,,,,,
79,75,P,S,,,,,,,,,,d,"WW domain ligands, 74-79, ELM|SH3 ligand, 72-78, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929751-929751","hg19,19:g.929751C>T",0.082,,,,
80,76,A,T,,,,,,,,,,d,"WW domain ligands, 74-79, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,19:929754-929754","hg38,19:g.929754G>A",0.010,thyroid,carcinoma,,
81,76,A,V,,,,,,,,,,d,"WW domain ligands, 74-79, ELM|SH3 ligand, 72-78, ELM",,COSMIC,,,"hg38,19:929755-929755","hg38,19:g.929755C>T",0.068,thyroid,carcinoma,0.0000000000000000,
82,77,S,,P,,,,,,,,,d,"WW domain ligands, 74-79, ELM|SH3 ligand, 72-78, ELM",,,,,,,,,,,
83,78,P,,,,,,,,,,,d,"USP7 binding motif, 78-82, ELM|WW domain ligands, 74-79, ELM|SH3 ligand, 72-78, ELM",,,,,,,,,,,
84,79,G,,,,,,,,,,,d,"USP7 binding motif, 78-82, ELM|WW domain ligands, 74-79, ELM",,,,,,,,,,,
85,80,G,S,,,,,,,,,,d,"USP7 binding motif, 78-82, ELM",,COSMIC,,,"hg38,19:929766-929766","hg38,19:g.929766G>A",0.080,"large_intestine, colon","carcinoma, adenocarcinoma",0.0001184678162433,0.0000638732754216
86,81,S,,P,,,,,,,,,d,"USP7 binding motif, 78-82, ELM",,,,,,,,,,,
87,82,E,,,,,,,,,,,d,"USP7 binding motif, 78-82, ELM",,,,,,,,,,,
88,83,D,,,,,,,,,,,d,,,,,,,,,,,,
89,84,G,,,,,,,,,,,d,,,,,,,,,,,,
90,85,P,,,,,,,,,,,d,,,,,,,,,,,,
91,86,P,L,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929785-929785","hg38,19:g.929785C>T",0.027,stomach,"carcinoma, diffuse_adenocarcinoma",0.0000201946766832,
92,87,G,C,,,,,,,,,,d,,,cBioPortal,"metastatic_solid_tumors_mich_2017, prad_p1000, prad_su2c_2019","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:929787-929787","hg19,19:g.929787G>T",0.111,,,,
93,88,S,,P,,,,,,,,,d,"TRAF2 binding site, 88-91, ELM",,,,,,,,,,,
94,89,E,D,,,,,,,,,,d,"TRAF2 binding site, 88-91, ELM",,COSMIC,,,"hg38,19:929795-929795","hg38,19:g.929795G>C, hg38,19:g.929795G>T",0.106,"thyroid, upper_aerodigestive_tract, mouth",carcinoma,,
95,89,E,K,,,,,,,,,,d,"TRAF2 binding site, 88-91, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929793-929793","hg19,19:g.929793G>A",0.083,,,,
96,90,E,K,,,,,,,,,,d,"TRAF2 binding site, 88-91, ELM",,COSMIC,,,"hg38,19:929796-929796","hg38,19:g.929796G>A",0.134,"central_nervous_system, brain","glioma, gliomatosis_cerebri",0.0000067959713482,
97,91,E,,,,,,,,,,,d,"TRAF2 binding site, 88-91, ELM",,,,,,,,,,,
98,92,D,,,,,,,,,,,d,,,,,,,,,,,,
99,93,A,T,,,,,,,,,,d,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:929805-929805, hg38,19:929805-929805","hg19,19:g.929805G>A, hg38,19:g.929805G>A",0.016,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,0.0000481788398535,
100,94,A,,,,,,,,,,,d,,,,,,,,,,,,
101,95,R,Q,,,,,,,,,,d,"WW domain ligands, 95-100, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,19:929812-929813",,,,,,
102,95,R,W,,,,,,,,,,d,"WW domain ligands, 95-100, ELM",,COSMIC,,,"hg38,19:929811-929811","hg38,19:g.929811C>T",0.131,large_intestine,"carcinoma, adenocarcinoma",0.0000206148729437,0.0000639795265515
103,96,E,,,,,,,,,,,d,"WW domain ligands, 95-100, ELM|SH3 ligand, 96-102, ELM",,,,,,,,,,,
104,97,G,,,,,,,,,,,d,"WW domain ligands, 95-100, ELM|SH3 ligand, 96-102, ELM",,,,,,,,,,,
105,98,T,I,P,,,,,,,,,d,"WW domain ligands, 95-100, ELM|WW domain ligands, 98-103, ELM|SH3 ligand, 96-102, ELM",,"cBioPortal,COSMIC","thca_tcga, thca_tcga_pub",Papillary Thyroid Cancer,"hg19,19:929821-929821, hg38,19:929821-929821","hg19,19:g.929821C>T, hg38,19:g.929821C>T",0.017,thyroid,carcinoma,,
106,99,P,,,,,,,,,,,d,"WW domain ligands, 95-100, ELM|WW domain ligands, 98-103, ELM|SH3 ligand, 99-104, ELM|SH3 ligand, 96-102, ELM",,,,,,,,,,,
107,100,G,,,,,,,,,,,d,"WW domain ligands, 95-100, ELM|WW domain ligands, 98-103, ELM|SH3 ligand, 99-104, ELM|SH3 ligand, 96-102, ELM",,,,,,,,,,,
108,101,S,L,P,,,,,,,,,d,"WW domain ligands, 98-103, ELM|SH3 ligand, 99-104, ELM|SH3 ligand, 96-102, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,19:929830-929830, hg38,19:929830-929830","hg19,19:g.929830C>T, hg38,19:g.929830C>T",0.049,breast,carcinoma,,
109,102,P,,,,,,,,,,,d,"WW domain ligands, 98-103, ELM|SH3 ligand, 99-104, ELM|SH3 ligand, 96-102, ELM",,,,,,,,,,,
110,103,G,R,,,,,,,,,,d,"WW domain ligands, 98-103, ELM|SH3 ligand, 99-104, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:929835-929835","hg19,19:g.929835G>A",0.051,,,0.0000476371951220,0.0000319652218386
111,104,R,Q,,,,,,,,,,d,"SH3 ligand, 99-104, ELM",,COSMIC,,,"hg38,19:929839-929839","hg38,19:g.929839G>A",0.069,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000067876681645,
112,105,G,,,,,,,,,,,d,,,,,,,,,,,,
113,106,R,G,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929844-929844","hg38,19:g.929844A>G",0.012,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0016332782130174,0.0014367816091954
114,107,E,,,,,,,,,,,d,"TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
115,108,G,,,,,,,,,,,d,"TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
116,109,P,,,,,,,,,,,d,"TRAF2 binding site, 109-112, ELM|TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
117,110,G,,,,,,,,,,,d,"TRAF2 binding site, 109-112, ELM|TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
118,111,E,,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|TRAF2 binding site, 109-112, ELM|TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
119,112,E,,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM|TRAF2 binding site, 109-112, ELM|TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
120,113,H,,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM|TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
121,114,F,,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM|TRAF6 binding site, 107-115, ELM",,,,,,,,,,,
122,115,E,K,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM|TRAF6 binding site, 107-115, ELM",,COSMIC,,,"hg38,19:929871-929871","hg38,19:g.929871G>A",0.030,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,
123,116,D,Y,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM",,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,19:929874-929874, hg38,19:929874-929874","hg19,19:g.929874G>T, hg38,19:g.929874G>T",0.113,soft_tissue,sarcoma,,
124,117,M,,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM",,,,,,,,,,,
125,118,A,D,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM",,cBioPortal,mixed_pipseq_2017,Mixed Cancer Types,"hg19,19:929881-929881","hg19,19:g.929881C>A",0.098,,,,
126,118,A,T,,,,,,,,,,d,"Atg8 protein family ligands, 111-118, ELM|Atg8 protein family ligands, 112-118, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:929880-929880","hg19,19:g.929880G>A",0.090,,,,
127,119,S,,P,,,,,,,,,d,,,,,,,,,,,,
128,120,D,,,,,,,,,,,d,,,,,,,,,,,,
129,121,E,K,,,,,,,,,,d,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:929889-929889","hg19,19:g.929889G>A",0.088,,,0.0000346620450607,0.0000956754688098
130,122,D,,,,,,,,,,,d,,,,,,,,,,,,
131,123,M,V,,,,,,,,,,d,,,COSMIC,,,"hg38,19:929895-929895","hg38,19:g.929895A>G",0.064,"soft_tissue, striated_muscle","rhabdomyosarcoma, alveolar",0.0000138607823026,0.0000318918229366
132,124,K,,,,,,,,,,,d,,,,,,,,,,,,
133,125,P,L,,,,,,,,,,d,,,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:932423-932423","hg19,19:g.932423C>T",0.033,,,,
134,126,K,,,,,,,,,,,d,,,,,,,,,,,,
135,127,W,,,,,,,,,,,d,,,,,,,,,,,,
136,128,E,,,,,,,,,,,d,,,,,,,,,,,,
137,129,E,,,,,,,,,,,d,,,,,,,,,,,,
138,130,E,,,,,,,,,,,d,,,,,,,,,,,,
139,131,E,,,,,,,,,,,d,,,,,,,,,,,,
140,132,M,,,,,,,,,,,d,,,,,,,,,,,,
141,133,E,,,,,,,,,,,d,,,,,,,,,,,,
142,134,E,,,,,,,,,,,d,,,,,,,,,,,,
143,135,D,,,,,,,,,,,d,,,,,,,,,,,,
144,136,L,,,,,,,,,,,d,,,,,,,,,,,,
145,137,G,,,,,,,,,,,d,,,,,,,,,,,,
146,138,E,,,,,,,,,,,d,,,,,,,,,,,,
147,139,D,,,,,,,,,,,d,,,,,,,,,,,,
148,140,E,,,,,,,,,,,d,,,,,,,,,,,,
149,141,E,D,,,,,,,,,,d,,,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,19:932472-932472, hg38,19:932472-932472","hg19,19:g.932472G>C, hg38,19:g.932472G>C",0.040,liver,"carcinoma, hepatocellular_carcinoma",,
150,142,E,,,,,,,,,,,d,,,,,,,,,,,,
151,143,E,G,,,,,,,,,,d,,,cBioPortal,lihc_tcga,Hepatocellular Carcinoma,"hg19,19:932477-932477","hg19,19:g.932477A>G",0.044,,,,
152,144,E,,,,,,,,,,,d,,,,,,,,,,,,
153,145,E,D,,,,,,,,,,d,,,cBioPortal,tgct_tcga,Non-Seminomatous Germ Cell Tumor,"hg19,19:932484-932484","hg19,19:g.932484G>T",0.061,,,,
154,146,D,,,,,,,,,,,d,,,,,,,,,,,,
155,147,Y,,,,,,,,,,,d,,,,,,,,,,,,
156,148,E,,,,,,,,,,,d,,,,,,,,,,,,
157,149,D,E,,,,,,,,,,d,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:932496-932496","hg19,19:g.932496T>G",0.078,,,0.0000282689507979,0.0000653253200941
158,150,E,,,,,,,,,,,d,,,,,,,,,,,,
159,151,E,,,,,,,,,,,d,,,,,,,,,,,,
160,152,E,Q,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932503-932503","hg19,19:g.932503G>C",0.082,,,0.0000183123351890,0.0001274859765426
161,153,E,,,,,,,,,,,d,,,,,,,,,,,,
162,154,E,,,,,,,,,,,d,,,,,,,,,,,,
163,155,D,E,,,,,,,,,,d,,,COSMIC,,,"hg38,19:932514-932514","hg38,19:g.932514C>A",0.020,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",0.0000000000000000,
164,156,E,,,,,,,,,,,d,,,,,,,,,,,,
165,157,E,,,,,,,,,,,d,,,,,,,,,,,,
166,158,G,,,,,,,,,,,d,"SH3 ligand, 158-164, ELM",,,,,,,,,,,
167,159,L,,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 159-162, ELM|SH3 ligand, 158-164, ELM",,,,,,,,,,,
168,160,G,,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 159-162, ELM|SH3 ligand, 158-164, ELM",,,,,,,,,,,
169,161,P,L,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 159-162, ELM|SH3 ligand, 158-164, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:932531-932531, hg38,19:932531-932531","hg19,19:g.932531C>T, hg38,19:g.932531C>T",0.055,skin,"carcinoma, basal_cell_carcinoma",,
170,161,P,S,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 159-162, ELM|SH3 ligand, 158-164, ELM",,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:932530-932530","hg19,19:g.932530C>T",0.054,,,,
171,162,P,,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 159-162, ELM|SH3 ligand, 158-164, ELM",,,,,,,,,,,
172,163,G,,,,,,,,,,,d,"SH3 ligand, 158-164, ELM",,,,,,,,,,,
173,164,P,S,,,,,,,,,,d,"SH3 ligand, 158-164, ELM",,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018",Papillary Renal Cell Carcinoma,"hg19,19:932539-932539, hg38,19:932539-932539","hg19,19:g.932539C>T, hg38,19:g.932539C>T",0.054,kidney,"carcinoma, papillary_renal_cell_carcinoma",,
174,165,A,D,,,,,,,,,,d,,,COSMIC,,,"hg38,19:932543-932543","hg38,19:g.932543C>A",0.066,thyroid,carcinoma,,
175,166,S,,,,,,,,,,,d,,,,,,,,,,,,
176,167,L,,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,,,,,,,,,,
177,168,G,,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,,,,,,,,,,
178,169,T,,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,,,,,,,,,,
179,170,T,,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,,,,,,,,,,
180,171,A,,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,,,,,,,,,,
181,172,L,,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,,,,,,,,,,
182,173,F,Y,,,,,,,,,,d,"FHA phosphopeptide ligands, 167-173, ELM",,COSMIC,,,"hg38,19:932567-932567","hg38,19:g.932567T>A",0.111,thyroid,carcinoma,,
183,174,P,,,,,,,,,,,d,"NRD cleavage site, 174-176, ELM",,,,,,,,,,,
184,175,R,G,,,,,,,,,,d,"NRD cleavage site, 174-176, ELM",,cBioPortal,"acc_tcga, acc_tcga_pan_can_atlas_2018",Adrenocortical Carcinoma,"hg19,19:932572-932572","hg19,19:g.932572C>G",0.114,,,,
185,175,R,Q,,,,,,,,,,d,"NRD cleavage site, 174-176, ELM",,"cBioPortal,COSMIC",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:932573-932573, hg38,19:932573-932573","hg19,19:g.932573G>A, hg38,19:g.932573G>A",0.097,"skin, lower_extremity","carcinoma, Merkel_cell_carcinoma",0.0000000000000000,
186,176,K,R,,,,,,,,,,d,"NRD cleavage site, 174-176, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:932576-932576, hg38,19:932576-932576","hg19,19:g.932576A>G, hg38,19:g.932576A>G",0.068,pancreas,"carcinoma, ductal_carcinoma",,
187,177,A,G,,,,,,,,,,d,,,"cBioPortal,COSMIC","mixed_allen_2018, prad_fhcrc","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,19:932579-932579, hg38,19:932579-932579","hg19,19:g.932579C>G, hg38,19:g.932579C>G",0.054,prostate,"carcinoma, adenocarcinoma",,
188,178,Q,,,,,,,,,,,d,,,,,,,,,,,,
189,179,P,S,,,,,,,,,,d,"EVH1  ligands, 179-183, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,19:932584-932584, hg38,19:932584-932584","hg19,19:g.932584C>T, hg38,19:g.932584C>T",0.080,"large_intestine, caecum","carcinoma, adenocarcinoma",,
190,180,P,,,,,,,,,,,d,"EVH1  ligands, 179-183, ELM",,,,,,,,,,,
191,181,Q,,,,,,,,,,,d,"EVH1  ligands, 179-183, ELM",,,,,,,,,,,
192,182,A,G,,,,,,,,,,d,"EVH1  ligands, 179-183, ELM",,COSMIC,,,"hg38,19:932594-932594","hg38,19:g.932594C>G",0.034,"large_intestine, colon","carcinoma, adenocarcinoma",,
193,183,F,,,,,,,,,,,d,"EVH1  ligands, 179-183, ELM",,,,,,,,,,,
194,184,R,C,,,,,,,,,,d,"Integrin RGD-type binding sites, 184-186, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932599-932599","hg19,19:g.932599C>T",0.122,,,0.0000683900971139,
195,185,G,,,,,,,,,,,d,"Integrin RGD-type binding sites, 184-186, ELM",,,,,,,,,,,
196,186,D,,,,,,,,,,,d,"Integrin RGD-type binding sites, 184-186, ELM",,,,,,,,,,,
197,187,G,,,,,,,,,,,d,,,,,,,,,,,,
198,188,V,,,,,,,,,,,d,,,,,,,,,,,,
199,189,P,,,,,,,,,,,d,,,,,,,,,,,,
200,190,R,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
201,191,V,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
202,192,L,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
203,193,G,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
204,194,G,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
205,195,Q,H,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,COSMIC,,,"hg38,19:932634-932634","hg38,19:g.932634G>T",0.042,liver,"other, neoplasm",,
206,196,E,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
207,197,R,W,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,COSMIC,,,"hg38,19:932638-932638","hg38,19:g.932638C>T",0.182,breast,"carcinoma, ductal_carcinoma",0.0000076664775602,
208,198,P,,,,,,,,,,,d,"MAD2 binding motif, 190-198, ELM",,,,,,,,,,,
209,199,G,R,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932644-932644","hg19,19:g.932644G>A",0.110,,,,
210,199,G,W,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:932644-932644","hg19,19:g.932644G>T",0.091,,,,
211,200,P,,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,,,,,,,,,,
212,201,G,,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,,,,,,,,,,
213,202,P,,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,,,,,,,,,,
214,203,A,,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,,,,,,,,,,
215,204,H,,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,,,,,,,,,,
216,205,P,,,,,,,,,,,d,"SH3 ligand, 199-205, ELM",,,,,,,,,,,
217,206,G,R,,,,,,,,,,d,,,COSMIC,,,"hg38,19:932665-932665","hg38,19:g.932665G>A",0.060,pancreas,carcinoma,0.0000144154533660,
218,207,G,R,,,,,,,,,,d,,,COSMIC,,,"hg38,19:932668-932668","hg38,19:g.932668G>A",0.135,"skin, trunk","malignant_melanoma, superficial_spreading",0.0000000000000000,
219,208,A,,,,,,,,,,,d,,,,,,,,,,,,
220,209,A,,,,,,,,,,,d,,,,,,,,,,,,
221,210,H,,,,,,,,,,,d,,,,,,,,,,,,
222,211,V,,,,,,,,,,,d,,,,,,,,,,,,
223,212,A,V,,,,,,,,,,d,,,"cBioPortal,COSMIC",stad_pfizer_uhongkong,Stomach Adenocarcinoma,"hg19,19:932684-932684, hg38,19:932684-932684","hg19,19:g.932684C>T, hg38,19:g.932684C>T",0.003,stomach,"carcinoma, intestinal_adenocarcinoma",0.0000071130838064,
224,213,P,,,,,,,,,,,d,"MYND domain binding motif., 213-217, ELM",,,,,,,,,,,
225,214,Q,,,,,,,,,,,d,"MYND domain binding motif., 213-217, ELM",,,,,,,,,,,
226,215,L,,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 215-218, ELM|MYND domain binding motif., 213-217, ELM",,,,,,,,,,,
227,216,Q,,,,,,,,,,,D,"Calcineurin (PP2B)-docking motif LxvP, 215-218, ELM|MYND domain binding motif., 213-217, ELM",,,,,,,,,,,
228,217,P,,,,,,,,,,,D,"Calcineurin (PP2B)-docking motif LxvP, 215-218, ELM|MYND domain binding motif., 213-217, ELM",,,,,,,,,,,
229,218,P,,,,,,,,,,,C,"Calcineurin (PP2B)-docking motif LxvP, 215-218, ELM",,,,,,,,,,,
230,219,D,,,,,,,,,,,C,,,,,,,,,,,,
231,220,H,Q,,,,,,,,,,C,,,COSMIC,,,"hg38,19:932709-932709","hg38,19:g.932709C>A",0.109,liver,"other, neoplasm",,
232,221,G,,,,,,,,,,,C,,,,,,,,,,,,
233,222,D,,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,,,,,,,,,,
234,223,W,R,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,"cBioPortal,COSMIC",kirp_tcga_pan_can_atlas_2018,Papillary Renal Cell Carcinoma,"hg19,19:932716-932716, hg38,19:932716-932716","hg19,19:g.932716T>C, hg38,19:g.932716T>C",0.324,kidney,"carcinoma, papillary_renal_cell_carcinoma",,
235,224,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|TRAF2 binding site, 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,,,,,,,,,,
236,225,Y,,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-228, ELM|TRAF2 binding site, 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,,,,,,,,,,
237,226,E,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-228, ELM|TRAF2 binding site, 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:932725-932725","hg19,19:g.932725G>A",0.233,,,,
238,227,E,,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-228, ELM|TRAF2 binding site, 224-227, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,,,,,,,,,,
239,228,Q,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 222-228, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-229, ELM|Phosphotyrosine ligands bound by SH2 domains, 225-228, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,COSMIC,,,"hg38,19:932731-932731","hg38,19:g.932731C>A",0.196,"skin, mucosal, female_genital_tract_(site_indeterminate)",malignant_melanoma,,
240,229,F,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 225-229, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 222-229, ELM",,,,,,,,,,,
241,230,K,,,,,,,,,,,S,,,,,,,,,,,,
242,231,Q,H,,,,,,,,,,S,,,COSMIC,,,"hg38,19:932742-932742","hg38,19:g.932742G>T",0.214,thyroid,carcinoma,,
243,232,L,,,,,,,,,,,S,,,,,,,,,,,,
244,233,Y,,,,,,,,,,,S,,,,,,,,,,,,
245,234,E,K,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:960098-960098","hg19,19:g.960098G>A",0.544,,,0.0000119949141564,
246,235,L,,,,,,,,,,,S,,,,,,,,,,,,
247,236,D,E,,,,,,,,,,S,,,"cBioPortal,COSMIC",mds_mskcc_2020,Myelodysplastic Syndromes,"hg19,19:960106-960106, hg38,19:960106-960106","hg19,19:g.960106C>A, hg38,19:g.960106C>A",0.276,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",,
248,236,D,N,,,,,,,,,,S,,,COSMIC,,,"hg38,19:960104-960104","hg38,19:g.960104G>A",0.477,oesophagus,"carcinoma, adenocarcinoma",0.0000079930939668,
249,237,G,W,,,,,,,,,,S,,,"cBioPortal,COSMIC","hnsc_tcga_pan_can_atlas_2018, skcm_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma","hg19,19:960107-960107, hg38,19:960107-960107","hg19,19:g.960107G>T, hg38,19:g.960107G>T",0.146,"skin, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma, malignant_melanoma",,
250,238,D,,,,,,,,,,,S,,,,,,,,,,,,
251,239,P,,,,,,,,,,,S,,,,,,,,,,,,
252,240,K,,,,Ubq,,,,,,,S,"NRD cleavage site, 240-242, ELM|PCSK cleavage site, 240-242, ELM",,,,,,,,,,,
253,241,R,M,,,,,,,,,,S,"NRD cleavage site, 240-242, ELM|PCSK cleavage site, 240-242, ELM",,COSMIC,,,"hg38,19:960120-960120","hg38,19:g.960120G>T",0.669,"upper_aerodigestive_tract, mouth",carcinoma,,
254,242,K,,,,,,,,,,,S,"NRD cleavage site, 240-242, ELM|PCSK cleavage site, 240-242, ELM|PCSK cleavage site, 242-246, ELM",,,,,,,,,,,
255,243,E,,,,,,,,,,,S,"PCSK cleavage site, 242-246, ELM",,,,,,,,,,,
256,244,F,,,,,,,,,,,S,"PCSK cleavage site, 242-246, ELM",,,,,,,,,,,
257,245,L,M,,,,,,,,,,S,"PCSK cleavage site, 242-246, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:960131-960131, hg38,19:960131-960131","hg19,19:g.960131C>A, hg38,19:g.960131C>A",0.470,skin,malignant_melanoma,,
258,245,L,V,,,,,,,,,,S,"PCSK cleavage site, 242-246, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,19:960131-960131, hg38,19:960131-960131","hg19,19:g.960131C>G, hg38,19:g.960131C>G",0.436,lung,"carcinoma, squamous_cell_carcinoma",,
259,246,D,,,,,,,,,,,S,"PCSK cleavage site, 242-246, ELM",,,,,,,,,,,
260,247,D,,,,,,,,,,,S,,,,,,,,,,,,
261,248,L,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 248-254, ELM|WAVE regulatory complex (WRC) binding site motif, 248-253, ELM",,,,,,,,,,,
262,249,F,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 248-254, ELM|WAVE regulatory complex (WRC) binding site motif, 248-253, ELM",,,,,,,,,,,
263,250,S,N,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 248-254, ELM|WAVE regulatory complex (WRC) binding site motif, 248-253, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:960147-960147, hg38,19:960147-960147","hg19,19:g.960147G>A, hg38,19:g.960147G>A",0.127,large_intestine,"carcinoma, adenocarcinoma",,
264,251,F,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 248-254, ELM|WAVE regulatory complex (WRC) binding site motif, 248-253, ELM",,,,,,,,,,,
265,252,M,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 248-254, ELM|WAVE regulatory complex (WRC) binding site motif, 248-253, ELM",,,,,,,,,,,
266,253,Q,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 248-254, ELM|WAVE regulatory complex (WRC) binding site motif, 248-253, ELM",,,,,,,,,,,
267,254,K,,,,,,,,,,,S,"PCSK cleavage site, 254-256, ELM|WW domain ligands, 254-259, ELM|Binding motif for UBA3 adenylation domain, 248-254, ELM",,,,,,,,,,,
268,255,R,Q,,,,,,,,,,S,"PCSK cleavage site, 254-256, ELM|WW domain ligands, 254-259, ELM",,"cBioPortal,COSMIC",mel_dfci_2019,Melanoma,"hg19,19:960162-960162, hg38,19:960162-960162","hg19,19:g.960162G>A, hg38,19:g.960162G>A",0.393,breast,"carcinoma, HER-positive_carcinoma",,
269,256,G,,,,,,,,,,,S,"PCSK cleavage site, 254-256, ELM|WW domain ligands, 254-259, ELM",,,,,,,,,,,
270,257,T,A,,,,,,,,,,S,"WW domain ligands, 254-259, ELM",,cBioPortal,panet_arcnet_2017,Pancreatic Neuroendocrine Tumor,"hg19,19:964250-964250","hg19,19:g.964250A>G",0.436,,,,
271,258,P,,,,,,,,,,,S,"WW domain ligands, 254-259, ELM",,,,,,,,,,,
272,259,V,,,,,,,,,,,S,"WW domain ligands, 254-259, ELM",,,,,,,,,,,
273,260,N,,,,,,,,,,,S,,,,,,,,,,,,
274,261,R,C,,,,,,,,,,S,,,COSMIC,,,"hg38,19:964262-964262","hg38,19:g.964262C>T",0.586,"skin, mucosal, nasopharynx",malignant_melanoma,,
275,261,R,H,,,,,,,,,,S,,,"cBioPortal,COSMIC","ccle_broad_2019, difg_glass_2019, gbm_tcga, gbm_tcga_pub2013, thca_tcga_pan_can_atlas_2018","Diffuse Glioma, Glioblastoma Multiforme, Mixed Cancer Types, Papillary Thyroid Cancer","hg19,19:964263-964263, hg38,19:964263-964263","hg19,19:g.964263G>A, hg38,19:g.964263G>A",0.503,"skin, mucosal, anorectal, thyroid","carcinoma, malignant_melanoma",,
276,262,I,,,,,,,,,,,S,,,,,,,,,,,,
277,263,P,H,,,,,,,,,,S,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:964269-964269, hg38,19:964269-964269","hg19,19:g.964269C>A, hg38,19:g.964269C>A",0.952,skin,malignant_melanoma,,
278,264,I,M,,,,,,,,,,S,,,"cBioPortal,COSMIC",escc_icgc,Esophageal Squamous Cell Carcinoma,"hg19,19:964273-964273, hg38,19:964273-964273","hg19,19:g.964273C>G, hg38,19:g.964273C>G",0.344,oesophagus,carcinoma,,
279,264,I,V,,,,,,,,,,S,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,19:964271-964271, hg38,19:964271-964271","hg19,19:g.964271A>G, hg38,19:g.964271A>G",0.285,lung,"carcinoma, carcinoma, adenocarcinoma",,
280,265,M,,,,,,,,,,,S,,,,,,,,,,,,
281,266,A,,,,,,,,,,,S,,,,,,,,,,,,
282,267,K,,,,,,,,,,,S,"PCSK cleavage site, 267-271, ELM|MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM",,,,,,,,,,,
283,268,Q,,,,,,,,,,,S,"PCSK cleavage site, 267-271, ELM|MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
284,269,V,,,,,,,,,,,S,"PCSK cleavage site, 267-271, ELM|MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
285,270,L,I,,,,,,,,,,S,"PCSK cleavage site, 267-271, ELM|MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|NES Nuclear Export Signal, 268-281, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:964289-964289, hg38,19:964289-964289","hg19,19:g.964289C>A, hg38,19:g.964289C>A",0.383,skin,malignant_melanoma,,
286,271,D,,,,,,,,,,,S,"PCSK cleavage site, 267-271, ELM|MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
287,272,L,,,,,,,,,,,S,"MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
288,273,F,,,,,,,,,,,S,"MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
289,274,M,T,,,,,,,,,,S,"MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|NES Nuclear Export Signal, 268-281, ELM",,"cBioPortal,COSMIC",kirc_tcga_pub,Renal Clear Cell Carcinoma,"hg19,19:964302-964302, hg38,19:964302-964302","hg19,19:g.964302T>C, hg38,19:g.964302T>C",0.264,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
290,274,M,V,,,,,,,,,,S,"MAPK docking motifs, 267-274, ELM|MAPK docking motifs, 267-275, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|NES Nuclear Export Signal, 268-281, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,19:964301-964301","hg19,19:g.964301A>G",0.311,,,,
291,275,L,,,,,,,,,,,S,"MAPK docking motifs, 267-275, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
292,276,Y,,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|Y-based sorting signal, 276-279, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
293,277,V,M,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|Y-based sorting signal, 276-279, ELM|NES Nuclear Export Signal, 268-281, ELM",,"cBioPortal,COSMIC",sarc_tcga_pan_can_atlas_2018,Soft Tissue,"hg19,19:964310-964310, hg38,19:964310-964310","hg19,19:g.964310G>A, hg38,19:g.964310G>A",0.056,"lung, soft_tissue, upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, carcinoma, nasopharyngeal_carcinoma, non_keratinizing, sarcoma",0.0000079699056363,
294,278,L,M,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|Y-based sorting signal, 276-279, ELM|NES Nuclear Export Signal, 268-281, ELM",,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,19:964313-964313","hg19,19:g.964313C>A",0.454,,,,
295,279,V,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Phosphotyrosine ligands bound by SH2 domains, 276-279, ELM|Binding motif for UBA3 adenylation domain, 274-282, ELM|Y-based sorting signal, 276-279, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
296,280,T,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 274-282, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
297,281,E,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 274-282, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 281-286, ELM|NES Nuclear Export Signal, 268-281, ELM",,,,,,,,,,,
298,282,K,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 274-282, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 281-286, ELM",,,,,,,,,,,
299,283,G,D,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 281-286, ELM",,"cBioPortal,COSMIC","difg_glass_2019, prad_tcga_pan_can_atlas_2018","Diffuse Glioma, Prostate Adenocarcinoma","hg19,19:964329-964329, hg38,19:964329-964329","hg19,19:g.964329G>A, hg38,19:g.964329G>A",0.943,prostate,"carcinoma, adenocarcinoma",,
300,284,G,S,,,,,,,,,,S,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 281-286, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:964331-964331, hg38,19:964331-964331","hg19,19:g.964331G>A, hg38,19:g.964331G>A",0.963,endometrium,"carcinoma, endometrioid_carcinoma",,
301,285,L,I,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 281-286, ELM",,cBioPortal,"pcpg_tcga, pcpg_tcga_pub","Miscellaneous Neuroepithelial Tumor, Soft Tissue","hg19,19:964334-964334","hg19,19:g.964334C>A",0.325,,,,
302,286,V,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 281-286, ELM",,,,,,,,,,,
303,287,E,D,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, coadread_genentech","Colon Adenocarcinoma, Colorectal Adenocarcinoma","hg19,19:964342-964342, hg38,19:964342-964342","hg19,19:g.964342G>T, hg38,19:g.964342G>T",0.293,"large_intestine, colon","carcinoma, adenocarcinoma",,
304,288,V,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,,,,,,,,,,
305,289,I,M,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,19:964348-964348, hg38,19:964348-964348","hg19,19:g.964348C>G, hg38,19:g.964348C>G",0.409,breast,carcinoma,,
306,290,N,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,,,,,,,,,,
307,291,K,E,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:964352-964352","hg19,19:g.964352A>G",0.413,,,,
308,291,K,R,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,COSMIC,,,"hg38,19:964353-964353","hg38,19:g.964353A>G",0.227,stomach,carcinoma,,
309,292,K,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,,,,,,,,,,
310,293,L,,,,,,,,,,,S,"GTPase-binding domain (GBD) ligand, 285-293, ELM",,,,,,,,,,,
311,294,W,,,,,,,,,,,S,,,,,,,,,,,,
312,295,R,C,,,,,,,,,,S,"PCSK cleavage site, 295-299, ELM|Cyclin N-terminal Domain Docking Motifs, 295-306, ELM",,COSMIC,,,"hg38,19:964364-964364","hg38,19:g.964364C>T",0.518,stomach,carcinoma,,
313,296,E,,,,,,,,,,,S,"PCSK cleavage site, 295-299, ELM|Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
314,297,I,,,,,,,,,,,S,"PCSK cleavage site, 295-299, ELM|Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
315,298,T,,,,,,,,,,,S,"PCSK cleavage site, 295-299, ELM|Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
316,299,K,,,,,,,,,,,S,"PCSK cleavage site, 295-299, ELM|Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
317,300,G,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
318,301,L,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP, 301-304, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
319,302,N,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP, 301-304, ELM|FHA phosphopeptide ligands, 296-302, ELM",,,,,,,,,,,
320,303,L,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP, 301-304, ELM",,,,,,,,,,,
321,304,P,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM|Calcineurin (PP2B)-docking motif LxvP, 301-304, ELM",,,,,,,,,,,
322,305,T,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM",,,,,,,,,,,
323,306,S,,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 295-306, ELM|Cyclin N-terminal Domain Docking Motifs, 296-306, ELM",,,,,,,,,,,
324,307,I,,,,,,,,,,,S,,,,,,,,,,,,
325,308,T,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 308-312, ELM",,,,,,,,,,,
326,309,S,I,P,,,,,,,,,S,"BRCT phosphopeptide ligands, 308-312, ELM",,COSMIC,,,"hg38,19:964407-964407","hg38,19:g.964407G>T",0.816,thyroid,carcinoma,,
327,310,A,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 308-312, ELM",,,,,,,,,,,
328,311,A,T,,,,,,,,,,S,"BRCT phosphopeptide ligands, 308-312, ELM",,COSMIC,,,"hg38,19:964412-964412","hg38,19:g.964412G>A",0.638,liver,"other, neoplasm",,
329,312,F,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 308-312, ELM",,,,,,,,,,,
330,313,T,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,19:964419-964420, hg38,19:964419-964420","hg19,19:g.964419_964420delinsTT, hg38,19:g.964419_964420delinsTT",,skin,malignant_melanoma,,
331,314,L,,,,,,,,,,,S,,,,,,,,,,,,
332,315,R,W,,,,,,,,,,S,,,COSMIC,,,"hg38,19:964424-964424","hg38,19:g.964424C>T",0.796,endometrium,"carcinoma, endometrioid_carcinoma",,
333,316,T,S,,,,,,,,,,S,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:964428-964428, hg38,19:964428-964428","hg19,19:g.964428C>G, hg38,19:g.964428C>G",0.310,cervix,"carcinoma, squamous_cell_carcinoma",,
334,317,Q,,,,,,,,,,,S,,,,,,,,,,,,
335,318,Y,,,,,,,,,,,S,,,,,,,,,,,,
336,319,M,,,,,,,,,,,S,,,,,,,,,,,,
337,320,K,,,,,,,,,,,S,,,,,,,,,,,,
338,321,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM",,,,,,,,,,,
339,322,L,M,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,19:964846-964846, hg38,19:964846-964846","hg19,19:g.964846C>A, hg38,19:g.964846C>A",0.698,endometrium,"carcinoma, endometrioid_carcinoma",,
340,323,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM",,,,,,,,,,,
341,324,P,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM|Phosphotyrosine ligands bound by SH2 domains, 321-324, ELM",,,,,,,,,,,
342,325,Y,,,,,,,,,,,S,,,,,,,,,,,,
343,326,E,,,,,,,,,,,S,,,,,,,,,,,,
344,327,C,R,,,,,,,,,,S,,,"cBioPortal,COSMIC",difg_glass_2019,Diffuse Glioma,"hg19,19:964861-964861, hg38,19:964861-964861","hg19,19:g.964861T>C, hg38,19:g.964861T>C",0.668,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
345,328,E,,,,,,,,,,,S,,,,,,,,,,,,
346,329,K,,,,Ubq,,,,,,,S,"PCSK cleavage site, 329-331, ELM",,,,,,,,,,,
347,330,R,W,,,,,,,,,,S,"PCSK cleavage site, 329-331, ELM",,"cBioPortal,COSMIC","stad_tcga_pan_can_atlas_2018, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Stomach Adenocarcinoma","hg19,19:964870-964870, hg38,19:964870-964870","hg19,19:g.964870C>T, hg38,19:g.964870C>T",0.482,"endometrium, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000399376971924,0.0000318918229366
348,331,G,,,,,,,,,,,S,"PCSK cleavage site, 329-331, ELM",,,,,,,,,,,
349,332,L,F,,,,,,,,,,S,,,"cBioPortal,COSMIC",desm_broad_2015,Desmoplastic Melanoma,"hg19,19:964876-964876, hg38,19:964876-964876","hg19,19:g.964876C>T, hg38,19:g.964876C>T",0.371,"skin, forearm","malignant_melanoma, desmoplastic",,
350,333,S,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,19:964880-964880, hg38,19:964880-964880","hg19,19:g.964880G>A, hg38,19:g.964880G>A",0.374,skin,malignant_melanoma,,
351,334,N,,,,,,,,,,,S,,,,,,,,,,,,
352,335,P,,,,,,,,,,,S,,,,,,,,,,,,
353,336,N,S,,,,,,,,,,S,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:964889-964889, hg38,19:964889-964889","hg19,19:g.964889A>G, hg38,19:g.964889A>G",0.097,skin,"carcinoma, basal_cell_carcinoma",0.0000199358861900,
354,337,E,,,,,,,,,,,S,,,,,,,,,,,,
355,338,L,,,,,,,,,,,S,,,,,,,,,,,,
356,339,Q,,,,,,,,,,,S,,,,,,,,,,,,
357,340,A,,,,,,,,,,,S,,,,,,,,,,,,
358,341,A,,,,,,,,,,,S,"USP7 binding motif, 341-345, ELM",,,,,,,,,,,
359,342,I,,,,,,,,,,,S,"USP7 binding motif, 341-345, ELM",,,,,,,,,,,
360,343,D,,,,,,,,,,,S,"USP7 binding motif, 341-345, ELM",,,,,,,,,,,
361,344,S,,,,,,,,,,,S,"USP7 binding motif, 341-345, ELM",,,,,,,,,,,
362,345,N,,,,,,,,,,,C,"USP7 binding motif, 341-345, ELM",,,,,,,,,,,
363,346,R,,,,,,,,,,,C,"NRD cleavage site, 346-348, ELM|PCSK cleavage site, 346-352, ELM",,,,,,,,,,,
364,347,R,Q,,,,,,,,,,C,"NRD cleavage site, 346-348, ELM|PCSK cleavage site, 346-352, ELM",,"cBioPortal,COSMIC","nhl_bcgsc_2011, nhl_bcgsc_2013",Non-Hodgkin Lymphoma,"hg19,19:964922-964922, hg38,19:964922-964922","hg19,19:g.964922G>A, hg38,19:g.964922G>A",0.450,"haematopoietic_and_lymphoid_tissue, lymph_node","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
365,348,E,,,,,,,,,,,C,"NRD cleavage site, 346-348, ELM|PCSK cleavage site, 346-352, ELM",,,,,,,,,,,
366,349,G,,,,,,,,,,,C,"PCSK cleavage site, 346-352, ELM",,,,,,,,,,,
367,350,R,W,,,,,,,,,,C,"NRD cleavage site, 350-352, ELM|PCSK cleavage site, 346-352, ELM|14-3-3 binding phosphopeptide motif, 350-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,19:964930-964930, hg38,19:964930-964930","hg19,19:g.964930C>T, hg38,19:g.964930C>T",0.320,"pancreas, ampulla_of_Vater","carcinoma, ductal_carcinoma",,
368,351,R,L,,,,,,,,,,C,"NRD cleavage site, 350-352, ELM|PCSK cleavage site, 346-352, ELM|14-3-3 binding phosphopeptide motif, 350-355, ELM|14-3-3 binding phosphopeptide motif, 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,cBioPortal,lihc_amc_prv,Hepatocellular Carcinoma,"hg19,19:964934-964934","hg19,19:g.964934G>T",0.506,,,,
369,352,Q,H,,,,,,,,,,s,"NRD cleavage site, 350-352, ELM|PCSK cleavage site, 346-352, ELM|14-3-3 binding phosphopeptide motif, 350-355, ELM|14-3-3 binding phosphopeptide motif, 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:964938-964938","hg19,19:g.964938G>C",0.204,,,,
370,353,S,,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 350-355, ELM|14-3-3 binding phosphopeptide motif, 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,,,,,,,,,,
371,354,F,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 350-355, ELM|14-3-3 binding phosphopeptide motif, 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,,,,,,,,,,
372,355,G,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 350-355, ELM|14-3-3 binding phosphopeptide motif, 351-355, ELM|Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,,,,,,,,,,
373,356,G,C,,,,,,,,,,s,"Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,19:964948-964948","hg19,19:g.964948G>T",0.153,,,,
374,357,S,F,P,,,,,,,,,s,"Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,"cBioPortal,COSMIC",brca_sanger,Invasive Breast Carcinoma,"hg19,19:964952-964952, hg38,19:964952-964952","hg19,19:g.964952C>T, hg38,19:g.964952C>T",0.228,breast,carcinoma,,
375,358,L,,,,,,,,,,,s,"Phospholigands for MAGUK family Guanylate Kinase-like Domains, 350-358, ELM",,,,,,,,,,,
376,359,F,,,,,,,,,,,s,"WW domain ligands, 359-364, ELM",,,,,,,,,,,
377,360,A,,,,,,,,,,,s,"WW domain ligands, 359-364, ELM",,,,,,,,,,,
378,361,Y,,P,,,,,,,,,s,"WW domain ligands, 359-364, ELM",,,,,,,,,,,
379,362,S,,P,,,,,,,,,s,"WW domain ligands, 359-364, ELM",,,,,,,,,,,
380,363,P,,,,,,,,,,,s,"WW domain ligands, 359-364, ELM",,,,,,,,,,,
381,364,G,,,,,,,,,,,s,"WW domain ligands, 359-364, ELM",,,,,,,,,,,
382,365,G,R,,,,,,,,,,s,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,19:964975-964975, hg38,19:964975-964975","hg19,19:g.964975G>A, hg38,19:g.964975G>A",0.269,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",0.0000119751874117,0.0000638243553740
383,365,G,V,,,,,,,,,,s,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:964976-964976, hg38,19:964976-964976","hg19,19:g.964976G>T, hg38,19:g.964976G>T",0.313,skin,malignant_melanoma,,
384,366,A,,,,,,,,,,,s,,,,,,,,,,,,
385,367,H,,,,,,,,,,,s,,,,,,,,,,,,
386,368,G,C,,,,,,,,,,s,,,"cBioPortal,COSMIC",mcl_idibips_2013,Mantle Cell Lymphoma,"hg19,19:964984-964984, hg38,19:964984-964984","hg19,19:g.964984G>T, hg38,19:g.964984G>T",0.129,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, mantle_cell_lymphoma",,
387,368,G,S,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:964984-964984","hg19,19:g.964984G>A",0.051,,,0.0000159745684870,
388,369,M,,,,,,,,,,,s,"WW domain ligands, 369-374, ELM",,,,,,,,,,,
389,370,L,,,,,,,,,,,s,"WW domain ligands, 369-374, ELM|SH3 ligand, 370-376, ELM",,,,,,,,,,,
390,371,S,,,,,,,,,,,s,"WW domain ligands, 369-374, ELM|SH3 ligand, 370-376, ELM",,,,,,,,,,,
391,372,S,,,,,,,,,,,s,"WW domain ligands, 369-374, ELM|SH3 ligand, 370-376, ELM",,,,,,,,,,,
392,373,P,S,,,,,,,,,,s,"WW domain ligands, 369-374, ELM|SH3 ligand, 370-376, ELM",,"cBioPortal,COSMIC",desm_broad_2015,Desmoplastic Melanoma,"hg19,19:964999-964999, hg38,19:964999-964999","hg19,19:g.964999C>T, hg38,19:g.964999C>T",0.161,"skin, upper_arm","malignant_melanoma, desmoplastic",0.0000039975055565,0.0000956876754274
393,374,K,,,,,,,,,,,s,"WW domain ligands, 369-374, ELM|SH3 ligand, 370-376, ELM",,,,,,,,,,,
394,375,L,,,,,,,,,,,s,"SH3 ligand, 370-376, ELM",,,,,,,,,,,
395,376,P,,,,,,,,,,,s,"USP7 binding motif, 376-380, ELM|SH3 ligand, 370-376, ELM",,,,,,,,,,,
396,377,V,M,,,,,,,,,,s,"USP7 binding motif, 376-380, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:965011-965011, hg38,19:965011-965011","hg19,19:g.965011G>A, hg38,19:g.965011G>A",0.070,"large_intestine, large_intestine, rectum","carcinoma, adenocarcinoma",0.0000200187375383,
397,378,S,F,,,,,,,,,,s,"USP7 binding motif, 376-380, ELM",,cBioPortal,skcm_dfci_2015,Cutaneous Melanoma,"hg19,19:965015-965015","hg19,19:g.965015C>T",0.175,,,,
398,379,S,F,,,,,,,,,,s,"USP7 binding motif, 376-380, ELM",,"cBioPortal,COSMIC","mixed_allen_2018, pancan_pcawg_2020, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:965018-965018, hg38,19:965018-965018","hg19,19:g.965018C>T, hg38,19:g.965018C>T",0.096,liver,carcinoma,,
399,380,L,,,,,,,,,,,s,"USP7 binding motif, 376-380, ELM",,,,,,,,,,,
400,381,G,,,,,,,,,,,s,,,,,,,,,,,,
401,382,L,,,,,,,,,,,s,,,,,,,,,,,,
402,383,A,,,,,,,,,,,s,,,,,,,,,,,,
403,384,A,,,,,,,,,,,s,,,,,,,,,,,,
404,385,S,,,,,,,,,,,s,,,,,,,,,,,,
405,386,T,,,,,,,,,,,s,,,,,,,,,,,,
406,387,N,,,,,,,,,,,s,,,,,,,,,,,,
407,388,G,,,,,,,,,,,s,,,,,,,,,,,,
408,389,S,,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,,,,,,,,,,
409,390,S,,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,,,,,,,,,,
410,391,I,,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,,,,,,,,,,
411,392,T,P,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,19:965056-965056","hg19,19:g.965056A>C",0.053,,,0.0173301172893505,0.0001922091235264
412,393,P,L,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,"cBioPortal,COSMIC","difg_glass_2019, mel_dfci_2019","Diffuse Glioma, Melanoma","hg19,19:965060-965060, hg38,19:965060-965060","hg19,19:g.965060C>T, hg38,19:g.965060C>T",0.174,large_intestine,"carcinoma, adenocarcinoma",,
413,393,P,S,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:965059-965059","hg19,19:g.965059C>T",0.046,,,,
414,394,A,T,,,,,,,,,,s,"WW domain ligands, 389-394, ELM",,"cBioPortal,COSMIC","skcm_yale, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Cutaneous Melanoma, Endometrial Carcinoma","hg19,19:965062-965062, hg38,19:965062-965062","hg19,19:g.965062G>A, hg38,19:g.965062G>A",0.014,"endometrium, skin","carcinoma, endometrioid_carcinoma, malignant_melanoma",0.0000774315545811,0.0003190199706502
415,395,P,,,,,,,,,,,s,,,,,,,,,,,,
416,396,K,,,,,,,,,,,s,,,,,,,,,,,,
417,397,I,S,,,,,,,,,,s,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:965072-965072, hg38,19:965072-965072","hg19,19:g.965072T>G, hg38,19:g.965072T>G",0.162,large_intestine,"carcinoma, adenocarcinoma",,
418,398,K,,,,,,,,Sumo,,,s,,,,,,,,,,,,
419,399,K,,,,,,,,,,,s,,,,,,,,,,,,
420,400,E,,,,,,,,,,,s,,,,,,,,,,,,
421,401,E,,,,,,,,,,,s,,,,,,,,,,,,
422,402,D,,,,,,,,,,,s,,,,,,,,,,,,
423,403,S,,,,,,,,,,,s,,,,,,,,,,,,
424,404,A,V,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966584-966584","hg38,19:g.966584C>T",0.098,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0120076985797448,0.0140359831568202
425,405,I,,,,,,,,,,,s,,,,,,,,,,,,
426,406,P,T,,,,,,,,,,s,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,19:966589-966589","hg19,19:g.966589C>A",0.080,,,0.0000045754445044,
427,407,I,,,,,,,,,,,s,,,,,,,,,,,,
428,408,T,,P,,,,,,,,,s,,,,,,,,,,,,
429,409,V,,,,,,,,,,,s,,,,,,,,,,,,
430,410,P,H,,,,,,,,,,s,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,19:966602-966602, hg38,19:966602-966602","hg19,19:g.966602C>A, hg38,19:g.966602C>A",0.265,skin,malignant_melanoma,,
431,410,P,S,,,,,,,,,,s,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,19:966601-966601","hg19,19:g.966601C>T",0.084,,,,
432,411,G,,,,,,,,,,,s,,,,,,,,,,,,
433,412,R,L,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,19:966608-966608, hg38,19:966608-966608","hg19,19:g.966608G>T, hg38,19:g.966608G>T",0.239,liver,"carcinoma, hepatocellular_carcinoma, other, neoplasm",,
434,413,L,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM",,,,,,,,,,,
435,414,P,L,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM|CtBP ligand motif, 414-418, ELM",,COSMIC,,,"hg38,19:966614-966614","hg38,19:g.966614C>T",0.175,"skin, shoulder","malignant_melanoma, malignant_melanoma, nodular",,
436,415,V,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM|CtBP ligand motif, 414-418, ELM",,,,,,,,,,,
437,416,S,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM|CtBP ligand motif, 414-418, ELM",,,,,,,,,,,
438,417,L,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM|CtBP ligand motif, 414-418, ELM",,,,,,,,,,,
439,418,A,V,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 412-418, ELM|CtBP ligand motif, 414-418, ELM",,"cBioPortal,COSMIC","prad_p1000, prad_su2c_2015, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,19:966626-966626, hg38,19:966626-966626","hg19,19:g.966626C>T, hg38,19:g.966626C>T",0.215,prostate,carcinoma,0.0000456333073362,
440,419,G,C,,,,,,,,,,s,,,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:966628-966628, hg38,19:966628-966628","hg19,19:g.966628G>T, hg38,19:g.966628G>T",0.340,lung,"carcinoma, adenocarcinoma",,
441,419,G,V,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966629-966629","hg38,19:g.966629G>T",0.160,oesophagus,"carcinoma, squamous_cell_carcinoma",,
442,420,H,,,,,,,,,,,s,,,,,,,,,,,,
443,421,P,L,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966635-966635","hg19,19:g.966635C>T",0.130,,,,
444,422,V,,,,,,,,,,,s,,,,,,,,,,,,
445,423,V,,,,,,,,,,,s,,,,,,,,,,,,
446,424,A,E,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966644-966644","hg38,19:g.966644C>A",0.122,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
447,424,A,T,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966643-966643","hg38,19:g.966643G>A",0.086,"oesophagus, middle_third","carcinoma, squamous_cell_carcinoma",,
448,424,A,V,,,,,,,,,,s,,,"cBioPortal,COSMIC",nccrcc_genentech_2014,Renal Non-Clear Cell Carcinoma,"hg19,19:966644-966644, hg38,19:966644-966644","hg19,19:g.966644C>T, hg38,19:g.966644C>T",0.079,kidney,"carcinoma, papillary_renal_cell_carcinoma",,
449,425,A,,,,,,,,,,,s,,,,,,,,,,,,
450,426,Q,,,,,,,,,,,s,,,,,,,,,,,,
451,427,A,,,,,,,,,,,s,,,,,,,,,,,,
452,428,A,,,,,,,,,,,s,,,,,,,,,,,,
453,429,A,T,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966658-966658","hg19,19:g.966658G>A",0.139,,,0.0000371673521978,
454,430,V,,,,,,,,,,,s,,,,,,,,,,,,
455,431,Q,,,,,,,,,,,s,,,,,,,,,,,,
456,432,A,T,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966667-966667","hg19,19:g.966667G>A",0.118,,,0.0000701615366202,
457,433,A,,,,,,,,,,,s,,,,,,,,,,,,
458,434,A,D,,,,,,,,,,s,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:966674-966674","hg19,19:g.966674C>A",0.201,,,,
459,435,A,T,,,,,,,,,,s,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:966676-966676, hg38,19:966676-966676","hg19,19:g.966676G>A, hg38,19:g.966676G>A",0.173,"large_intestine, large_intestine, caecum, large_intestine, colon","carcinoma, adenocarcinoma",0.0000123730728939,0.0000638121370685
460,436,Q,,,,,,,,,,,s,,,,,,,,,,,,
461,437,A,,,,,,,,,,,s,,,,,,,,,,,,
462,438,A,,,,,,,,,,,s,,,,,,,,,,,,
463,439,V,M,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966688-966688","hg38,19:g.966688G>A",0.058,lung,"carcinoma, adenocarcinoma",0.0000082231432143,
464,440,A,,,,,,,,,,,s,,,,,,,,,,,,
465,441,A,T,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966694-966694","hg19,19:g.966694G>A",0.114,,,,
466,442,Q,,,,,,,,,,,s,,,,,,,,,,,,
467,443,A,,,,,,,,,,,s,,,,,,,,,,,,
468,444,A,,,,,,,,,,,s,,,,,,,,,,,,
469,445,A,S,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966706-966706","hg38,19:g.966706G>T",0.093,liver,"other, neoplasm",,
470,446,L,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,,,,,,,,,,
471,447,E,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,,,,,,,,,,
472,448,Q,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,,,,,,,,,,
473,449,L,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,,,,,,,,,,
474,450,R,Q,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,19:966722-966722, hg38,19:966722-966722","hg19,19:g.966722G>A, hg38,19:g.966722G>A",0.235,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000243500564110,
475,450,R,W,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,cBioPortal,"ccle_broad_2019, gbm_tcga_pan_can_atlas_2018","Glioblastoma Multiforme, Mixed Cancer Types","hg19,19:966721-966721","hg19,19:g.966721C>T",0.318,,,0.0000243902439024,
476,451,E,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,,,,,,,,,,
477,452,K,,,,Ubq,,,,Sumo,,,s,"PP2A holoenzyme B56-docking site, 446-452, ELM",,,,,,,,,,,
478,453,L,,,,,,,,,,,s,,,,,,,,,,,,
479,454,E,,,,,,,,,,,s,,,,,,,,,,,,
480,455,S,,,,,,,,,,,s,,,,,,,,,,,,
481,456,A,V,,,,,,,,,,s,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:966740-966740, hg38,19:966740-966740","hg19,19:g.966740C>T, hg38,19:g.966740C>T",0.137,"endometrium, stomach","carcinoma, carcinoma, endometrioid_carcinoma",,
482,457,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC",pog570_bcgsc_2020,Mixed Cancer Types,"hg19,19:966742-966742, hg38,19:966742-966742","hg19,19:g.966742G>A, hg38,19:g.966742G>A",0.273,"urinary_tract, bladder",carcinoma,,
483,458,P,T,,,,,,,,,,s,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:966745-966745, hg38,19:966745-966745","hg19,19:g.966745C>A, hg38,19:g.966745C>A",0.280,stomach,"carcinoma, adenocarcinoma",,
484,459,P,A,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966748-966748","hg38,19:g.966748C>G",0.223,"upper_aerodigestive_tract, mouth",carcinoma,,
485,460,E,,,,,,,,,,,s,,,,,,,,,,,,
486,461,K,N,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966756-966756","hg38,19:g.966756G>T",0.205,"upper_aerodigestive_tract, mouth","carcinoma, squamous_cell_carcinoma",,
487,462,K,,,,,,,,Sumo,,,s,"PCSK cleavage site, 462-466, ELM",,,,,,,,,,,
488,463,M,,,,,,,,,,,s,"PCSK cleavage site, 462-466, ELM",,,,,,,,,,,
489,464,A,,,,,,,,,,,s,"PCSK cleavage site, 462-466, ELM",,,,,,,,,,,
490,465,L,,,,,,,,,,,s,"PCSK cleavage site, 462-466, ELM",,,,,,,,,,,
491,466,V,,,,,,,,,,,s,"PCSK cleavage site, 462-466, ELM",,,,,,,,,,,
492,467,A,V,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966773-966774","hg19,19:g.966773_966774delinsTT",,,,,
493,468,D,,,,,,,,,,,s,,,,,,,,,,,,
494,469,E,G,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 469-474, ELM",,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,19:966779-966779, hg38,19:966779-966779","hg19,19:g.966779A>G, hg38,19:g.966779A>G",0.393,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
495,470,Q,,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 469-474, ELM",,,,,,,,,,,
496,471,Q,,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 469-474, ELM",,,,,,,,,,,
497,472,R,,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 469-474, ELM",,,,,,,,,,,
498,473,L,,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 469-474, ELM",,,,,,,,,,,
499,474,M,T,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 469-474, ELM",,cBioPortal,luad_oncosg_2020,Lung Adenocarcinoma,"hg19,19:966794-966794","hg19,19:g.966794T>C",0.160,,,,
500,475,Q,,,,,,,,,,,s,,,,,,,,,,,,
501,476,R,C,,,,,,,,,,s,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,19:966799-966799, hg38,19:966799-966799","hg19,19:g.966799C>T, hg38,19:g.966799C>T",0.232,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000399007269912,
502,477,A,,,,,,,,,,,s,,,,,,,,,,,,
503,478,L,,,,,,,,,,,s,,,,,,,,,,,,
504,479,Q,,,,,,,,,,,s,,,,,,,,,,,,
505,480,Q,,,,,,,,,,,s,,,,,,,,,,,,
506,481,N,,,,,,,,,,,s,,,,,,,,,,,,
507,482,F,,,,,,,,,,,s,,,,,,,,,,,,
508,483,L,,,,,,,,,,,s,,,,,,,,,,,,
509,484,A,,,,,,,,,,,s,,,,,,,,,,,,
510,485,M,T,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966827-966827","hg38,19:g.966827T>C",0.321,stomach,"carcinoma, adenocarcinoma",,
511,486,A,,,,,,,,,,,s,,,,,,,,,,,,
512,487,A,S,,,,,,,,,,s,,,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,19:966832-966832","hg19,19:g.966832G>T",0.074,,,,
513,487,A,V,,,,,,,,,,s,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,19:966833-966833","hg19,19:g.966833C>T",0.115,,,,
514,488,Q,,,,,,,,,,,s,,,,,,,,,,,,
515,489,L,,,,,,,,,,,s,,,,,,,,,,,,
516,490,P,,,,,,,,,,,s,,,,,,,,,,,,
517,491,M,I,,,,,,,,,,s,,,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,19:966846-966846, hg38,19:966846-966846","hg19,19:g.966846G>C, hg38,19:g.966846G>A, hg38,19:g.966846G>C",0.171,"cervix, haematopoietic_and_lymphoid_tissue","carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0000040165159134,
518,492,S,,P,,,,,,,,,s,,,,,,,,,,,,
519,493,I,,,,,,,,,,,s,,,,,,,,,,,,
520,494,R,Q,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966854-966854","hg38,19:g.966854G>A",0.162,"large_intestine, thyroid","carcinoma, carcinoma, adenocarcinoma",0.0003749909276388,0.0012419591108847
521,494,R,W,,,,,,,,,,s,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:966853-966853","hg19,19:g.966853C>T",0.258,,,0.0000120959938069,
522,495,I,,,,,,,,,,,s,,,,,,,,,,,,
523,496,N,I,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:966860-966860","hg19,19:g.966860A>T",0.181,,,,
524,496,N,K,,,,,,,,,,s,,,COSMIC,,,"hg38,19:966861-966861","hg38,19:g.966861C>A",0.179,thyroid,carcinoma,,
525,497,S,,,,,,,,,,,d,,,,,,,,,,,,
526,498,Q,,,,,,,,,,,d,,,,,,,,,,,,
527,499,A,T,,,,,,,,,,d,"USP7 binding motif, 499-503, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,19:966868-966868, hg38,19:966868-966868","hg19,19:g.966868G>A, hg38,19:g.966868G>A",0.165,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
528,500,S,,,,,,,,,,,d,"USP7 binding motif, 499-503, ELM",,,,,,,,,,,
529,501,E,,,,,,,,,,,d,"USP7 binding motif, 499-503, ELM",,,,,,,,,,,
530,502,S,,,,,,,,,,,d,"Caspase cleavage motif, 502-506, ELM|USP7 binding motif, 499-503, ELM",,,,,,,,,,,
531,503,R,C,,,,,,,,,,d,"Caspase cleavage motif, 502-506, ELM|USP7 binding motif, 499-503, ELM",,COSMIC,,,"hg38,19:968416-968416","hg38,19:g.968416C>T",0.357,large_intestine,"carcinoma, adenocarcinoma",0.0000159309235156,0.0000319182891797
532,504,Q,,,,,,,,,,,d,"Caspase cleavage motif, 502-506, ELM",,,,,,,,,,,
533,505,D,,,,,,,,,,,d,"Caspase cleavage motif, 502-506, ELM",,,,,,,,,,,
534,506,S,,,,,,,,,,,d,"Caspase cleavage motif, 502-506, ELM",,,,,,,,,,,
535,507,A,,,,,,,,,,,d,,,,,,,,,,,,
536,508,V,,,,,,,,,,,d,,,,,,,,,,,,
537,509,N,,,,,,,,,,,d,,,,,,,,,,,,
538,510,L,,,,,,,,,,,d,,,,,,,,,,,,
539,511,T,,,,,,,,,,,d,,,,,,,,,,,,
540,512,G,,,,,,,,,,,d,,,,,,,,,,,,
541,513,T,I,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:968447-968447","hg19,19:g.968447C>T",0.126,,,,
542,514,N,I,,,,,,,,,,d,,,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,19:968450-968450, hg38,19:968450-968450","hg19,19:g.968450A>T, hg38,19:g.968450A>T",0.251,lung,"carcinoma, adenocarcinoma",,
543,514,N,S,,,,,,,,,,d,,,COSMIC,,,"hg38,19:968450-968450","hg38,19:g.968450A>G",0.124,lung,"carcinoma, adenocarcinoma",,
544,515,G,D,,,,,,,,,,d,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:968453-968453, hg38,19:968453-968453","hg19,19:g.968453G>A, hg38,19:g.968453G>A",0.515,large_intestine,"carcinoma, adenocarcinoma",,0.0000318775900542
545,516,S,,,,,,,,,,,d,,,,,,,,,,,,
546,517,N,,,,,,,,,,,s,,,,,,,,,,,,
547,518,S,N,,,,,,,,,,s,,,"cBioPortal,COSMIC","stad_oncosg_2018, stad_pfizer_uhongkong, stad_uhongkong",Stomach Adenocarcinoma,"hg19,19:968462-968462, hg38,19:968462-968462","hg19,19:g.968462G>A, hg38,19:g.968462G>A",0.349,stomach,"carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma",,
548,519,I,,,,,,,,,,,s,,,,,,,,,,,,
549,520,S,,,,,,,,,,,s,,,,,,,,,,,,
550,521,M,V,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:968470-968470","hg19,19:g.968470A>G",0.251,,,0.0000039796876741,
551,522,S,,,,,,,,,,,s,,,,,,,,,,,,
552,523,V,A,,,,,,,,,,s,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:968477-968477","hg19,19:g.968477T>C",0.295,,,,
553,524,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","pancan_pcawg_2020, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,19:968479-968479, hg38,19:968479-968479","hg19,19:g.968479G>A, hg38,19:g.968479G>A",0.532,skin,malignant_melanoma,,
554,525,I,,,,,,,,,,,s,,,,,,,,,,,,
555,526,N,,,,,,,,,,,s,,,,,,,,,,,,
556,527,G,C,,,,,,,,,,s,,,COSMIC,,,"hg38,19:968488-968488","hg38,19:g.968488G>T",0.700,thyroid,carcinoma,,
557,527,G,S,,,,,,,,,,s,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:968488-968488, hg38,19:968488-968488","hg19,19:g.968488G>A, hg38,19:g.968488G>A",0.651,large_intestine,"carcinoma, adenocarcinoma",0.0000119489540682,
558,528,I,,,,,,,,,,,s,"Immunoreceptor tyrosine-based motif, 528-533, ELM",,,,,,,,,,,
559,529,M,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Immunoreceptor tyrosine-based motif, 528-533, ELM",,COSMIC,,,"hg38,19:968496-968496","hg38,19:g.968496G>C",0.054,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
560,529,M,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Immunoreceptor tyrosine-based motif, 528-533, ELM",,"cBioPortal,COSMIC",tet_nci_2014,Thymic Epithelial Tumor,"hg19,19:968494-968494, hg38,19:968494-968494","hg19,19:g.968494A>G, hg38,19:g.968494A>G",0.011,thymus,"thymic_carcinoma, undifferentiated_carcinoma",0.0000039845399849,
561,530,Y,D,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-533, ELM|Immunoreceptor tyrosine-based motif, 528-533, ELM|Y-based sorting signal, 530-533, ELM",,"cBioPortal,COSMIC","ov_tcga, ov_tcga_pub",High-Grade Serous Ovarian Cancer,"hg19,19:968497-968497, hg38,19:968497-968497","hg19,19:g.968497T>G, hg38,19:g.968497T>G",0.578,ovary,"carcinoma, serous_carcinoma",,
562,531,T,,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-533, ELM|Immunoreceptor tyrosine-based motif, 528-533, ELM|Y-based sorting signal, 530-533, ELM",,,,,,,,,,,
563,532,G,R,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-533, ELM|Immunoreceptor tyrosine-based motif, 528-533, ELM|Y-based sorting signal, 530-533, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,19:968503-968503","hg19,19:g.968503G>A",0.717,,,,
564,533,V,F,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-534, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-533, ELM|Immunoreceptor tyrosine-based motif, 528-533, ELM|Y-based sorting signal, 530-533, ELM",,COSMIC,,,"hg38,19:971880-971880","hg38,19:g.971880G>T",0.275,liver,"other, neoplasm",,
565,534,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 529-535, ELM|Phosphotyrosine ligands bound by SH2 domains, 530-534, ELM",,,,,,,,,,,
566,535,F,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 535-538, ELM|FHA phosphopeptide ligands, 529-535, ELM|SH3 ligand, 535-541, ELM",,,,,,,,,,,
567,536,A,V,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 535-538, ELM|SH3 ligand, 535-541, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:971890-971890, hg38,19:971890-971890","hg19,19:g.971890C>T, hg38,19:g.971890C>T",0.243,endometrium,"carcinoma, endometrioid_carcinoma",,
568,537,Q,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 535-538, ELM|SH3 ligand, 535-541, ELM",,,,,,,,,,,
569,538,P,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 535-538, ELM|SH3 ligand, 535-541, ELM",,,,,,,,,,,
570,539,P,Q,,,,,,,,,,d,"WW domain ligands, 539-544, ELM|SH3 ligand, 535-541, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971899-971899","hg19,19:g.971899C>A",0.167,,,0.0000042593428686,
571,540,A,,,,,,,,,,,d,"WW domain ligands, 539-544, ELM|SH3 ligand, 535-541, ELM",,,,,,,,,,,
572,541,P,,,,,,,,,,,d,"WW domain ligands, 539-544, ELM|SH3 ligand, 535-541, ELM",,,,,,,,,,,
573,542,T,,,,,,,,,,,d,"WW domain ligands, 539-544, ELM",,,,,,,,,,,
574,543,P,,,,,,,,,,,d,"WW domain ligands, 539-544, ELM",,,,,,,,,,,
575,544,T,,,,,,,,,,,d,"WW domain ligands, 539-544, ELM",,,,,,,,,,,
576,545,S,,,,,,,,,,,d,,,,,,,,,,,,
577,546,A,,,,,,,,,,,d,,,,,,,,,,,,
578,547,P,L,,,,,,,,,,d,,,"cBioPortal,COSMIC","bcc_unige_2016, ccle_broad_2019, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,19:971923-971923, hg38,19:971923-971923","hg19,19:g.971923C>T, hg38,19:g.971923C>T",0.040,skin,"carcinoma, basal_cell_carcinoma, malignant_melanoma",,
579,547,P,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018",Cutaneous Melanoma,"hg19,19:971922-971922, hg38,19:971922-971922","hg19,19:g.971922C>T, hg38,19:g.971922C>T",0.017,skin,malignant_melanoma,0.0000042261497240,
580,548,N,K,,,,,,,,,,d,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,19:971927-971927, hg38,19:971927-971927","hg19,19:g.971927C>G, hg38,19:g.971927C>G",0.059,stomach,"carcinoma, adenocarcinoma",,
581,549,K,N,,,,,,,,,,d,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,19:971930-971930, hg38,19:971930-971930","hg19,19:g.971930A>T, hg38,19:g.971930A>T",0.134,lung,"carcinoma, non_small_cell_carcinoma",,
582,550,G,,,,,,,,,,,d,,,,,,,,,,,,
583,551,G,C,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971934-971934","hg19,19:g.971934G>T",0.142,,,,0.0000642384531380
584,551,G,S,,,,,,,,,,d,,,cBioPortal,pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:971934-971934","hg19,19:g.971934G>A",0.033,,,,
585,552,G,,,,,,,,,,,d,,,,,,,,,,,,
586,553,G,S,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971940-971940","hg19,19:g.971940G>A",0.025,,,0.0000393924804132,0.0000319631784185
587,554,G,R,,,,,,,,,,d,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,19:971943-971943, hg38,19:971943-971943","hg19,19:g.971943G>C, hg38,19:g.971943G>C",0.034,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
588,555,G,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,19:971946-971946, hg38,19:971946-971946","hg19,19:g.971946G>A, hg38,19:g.971946G>A",0.003,"endometrium, large_intestine, large_intestine, colon, transverse, stomach","carcinoma, carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000393098929897,0.0000319713536671
589,556,G,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","mds_mskcc_2020, mixed_pipseq_2017","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,19:971949-971949, hg38,19:971949-971949","hg19,19:g.971949G>A, hg38,19:g.971949G>A",0.020,"large_intestine, caecum, large_intestine, colon, liver, lung, thyroid","carcinoma, carcinoma, adenocarcinoma, other, neoplasm",0.7771939019026138,0.7821686436307375
590,557,S,G,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016, coadread_tcga_pan_can_atlas_2018, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,19:971952-971952, hg38,19:971952-971952","hg19,19:g.971952A>G, hg38,19:g.971952A>G",0.035,"endometrium, large_intestine, large_intestine, colon, ascending, large_intestine, colon, transverse, stomach","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma, carcinoma, intestinal_adenocarcinoma",0.0000301062319900,
591,558,S,N,,,,,,,,,,d,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:971956-971956","hg19,19:g.971956G>A",0.118,,,,
592,559,S,N,,,,,,,,,,d,,,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,19:971959-971959, hg38,19:971959-971959","hg19,19:g.971959G>A, hg38,19:g.971959G>A",0.040,large_intestine,"carcinoma, adenocarcinoma",,
593,560,N,,,,,,,,,,,d,,,,,,,,,,,,
594,561,A,,,,,,,,,,,d,,,,,,,,,,,,
595,562,G,,,,,,,,,,,d,,,,,,,,,,,,
596,563,G,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,19:971970-971970, hg38,19:971970-971970","hg19,19:g.971970G>A, hg38,19:g.971970G>A",0.006,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000298917917140,0.0000318877551020
597,564,R,,,,,,,,,,,d,,,,,,,,,,,,
598,565,G,,,,,,,,,,,d,,,,,,,,,,,,
599,566,G,E,,,,,,,,,,d,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,19:971980-971980, hg38,19:971980-971980","hg19,19:g.971980G>A, hg38,19:g.971980G>A",0.071,"skin, ear",malignant_melanoma,,
600,566,G,R,,,,,,,,,,d,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,19:971979-971979, hg38,19:971979-971979","hg19,19:g.971979G>A, hg38,19:g.971979G>A",0.060,skin,"carcinoma, basal_cell_carcinoma",0.0000000000000000,
601,567,N,,,,,,,,,,,d,,,,,,,,,,,,
602,568,T,,P,,,,,,,,,d,,,,,,,,,,,,
603,569,G,E,,,,,,,,,,d,,,COSMIC,,,"hg38,19:971989-971989","hg38,19:g.971989G>A",0.112,"biliary_tract, bile_duct",carcinoma,,
604,570,T,,,,,,,,,,,d,,,,,,,,,,,,
605,571,S,,,,,,,,,,,d,,,,,,,,,,,,
606,572,G,S,,,,,,,,,,d,,,"cBioPortal,COSMIC",pptc_2019,Mixed Cancer Types,"hg19,19:971997-971997, hg38,19:971997-971997","hg19,19:g.971997G>A, hg38,19:g.971997G>A",0.029,large_intestine,"carcinoma, adenocarcinoma",0.0000394266489101,
607,573,G,,,,,,,,,,,d,,,,,,,,,,,,
608,574,Q,,,,,,,,,,,d,,,,,,,,,,,,
609,575,A,,,,,,,,,,,d,,,,,,,,,,,,
610,576,G,E,,,,,,,,,,d,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:972010-972010","hg19,19:g.972010G>A",0.220,,,0.0000044510121602,0.0000319938571794
611,577,P,S,,,,,,,,,,d,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,19:972012-972012","hg19,19:g.972012C>T",0.052,,,0.0000044570430194,
612,578,A,V,,,,,,,,,,d,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,19:972016-972016","hg19,19:g.972016C>T",0.119,,,0.0000453650525781,
613,579,G,,,,,,,,,,,d,"WW domain ligands, 579-584, ELM",,,,,,,,,,,
614,580,L,,,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|Cks1 ligand, 580-585, ELM|WW domain ligands, 579-584, ELM",,,,,,,,,,,
615,581,S,,,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|Cks1 ligand, 580-585, ELM|WW domain ligands, 579-584, ELM",,,,,,,,,,,
616,582,T,,P,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|Cks1 ligand, 580-585, ELM|WW domain ligands, 579-584, ELM",,,,,,,,,,,
617,583,P,,,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|SPOP SBC docking motif, 583-587, ELM|Cks1 ligand, 580-585, ELM|USP7 binding motif, 583-587, ELM|WW domain ligands, 579-584, ELM",,,,,,,,,,,
618,584,S,,P,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|SPOP SBC docking motif, 583-587, ELM|Cks1 ligand, 580-585, ELM|USP7 binding motif, 583-587, ELM|WW domain ligands, 579-584, ELM",,,,,,,,,,,
619,585,T,,,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|SPOP SBC docking motif, 583-587, ELM|Cks1 ligand, 580-585, ELM|USP7 binding motif, 583-587, ELM",,,,,,,,,,,
620,586,S,F,,,,,,,,,,d,"SCF ubiquitin ligase binding Phosphodegrons, 580-586, ELM|SPOP SBC docking motif, 583-587, ELM|USP7 binding motif, 583-587, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,19:972040-972040","hg19,19:g.972040C>T",0.206,,,,
621,587,T,,,,,,,,,,,d,"SPOP SBC docking motif, 583-587, ELM|USP7 binding motif, 583-587, ELM",,,,,,,,,,,
622,588,S,,,,,,,,,,,d,,,,,,,,,,,,
623,589,N,,,,,,,,,,,d,,,,,,,,,,,,
624,590,N,,,,,,,,,,,d,,,,,,,,,,,,
625,591,S,L,P,,,,,,,,,d,,,"cBioPortal,COSMIC","sarc_tcga, sarc_tcga_pan_can_atlas_2018",Soft Tissue,"hg19,19:972055-972055, hg38,19:972055-972055","hg19,19:g.972055C>T, hg38,19:g.972055C>T",0.126,soft_tissue,sarcoma,0.0000000000000000,
626,592,L,,,,,,,,,,,d,,,,,,,,,,,,
627,593,P,,,,,,,,,,,d,,,,,,,,,,,,
